Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin
KIM K, KIM S, YU S, PARK S, CHOI H, YU H, JI J, SEO Y, AHN S. Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin. Molecular Medicine Reports 2015, 12: 1898-1904. PMID: 25892525, PMCID: PMC4464330, DOI: 10.3892/mmr.2015.3633.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic AgentsApoptosisATP Binding Cassette Transporter, Subfamily B, Member 1Breast NeoplasmsCell Line, TumorCell SurvivalDoxorubicinDrug Resistance, NeoplasmFemaleHumansMCF-7 CellsMultidrug Resistance-Associated ProteinsPyransConceptsEfflux of doxorubicinMCF-7/MDR cellsHuman breast cancer cellsBreast cancer cellsMultidrug resistanceMDR cellsCancer cellsReverses multidrug resistanceDose-dependent mannerMDR cancer therapyResistance of doxorubicinHuman multidrug resistanceNet cellular uptakeMDR-1Chemotherapeutic agentsMRP-1Cytometric analysisProtein levelsCancer therapyDoxorubicinExpression levelsAnticancer propertiesSalinomycinPresent studyEfflux